Evidence map›Paper›PMID 30143906›Full record

ArticleInternational journal of clinical oncology2019

Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future.

Masafumi Imamura, Koichi Hirata, Michiaki Unno, Kinj Kamiya, Mitsukazu Gotoh, Hiroyuki Konno, Akiko Shibata, Kenichi Sugihara, Arata Takahashi, Masahiko Nishiyama and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Masafumi ImamuraDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, 060-8543, Japan. imamura@sapmed.ac.jp.
Koichi HirataDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, 060-8543, Japan. kouichi.hirata@jrhokkaido.co.jp.
Michiaki UnnoDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kinj KamiyaSecond Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Mitsukazu GotohOsaka General Medical Center, Osaka, Japan.
Hiroyuki KonnoHamamatsu University School of Medicine, Hamamatsu, Japan.
Akiko ShibataNational Cancer Center, Center for Cancer Control and Information Services, Tokyo, Japan.
Kenichi SugiharaTokyo Medical and Dental University, Tokyo, Japan.
Arata TakahashiDepartment of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Masahiko NishiyamaDepartment of Molecular Pharmacology and Oncology, Gunma University Graduate School of Medicine, Maebash, Japan.
Kenichi HakamadaDepartment of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Tsuguya FukuiSt. Luke's International University, Tokyo, Japan.
Toshiharu FurukawaKeio University Law School, Tokyo, Japan.
Tsunekazu MizushimaDepartment of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Masamichi MizumaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroaki MiyataThe University of Tokyo, Healthcare Quality Assessment, Tokyo, Japan.
Masaki MoriDepartment of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Ichiro TakemasaDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, 060-8543, Japan.
Toru MizuguchiDepartment of Surgery, Surgical Oncology and Science, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, 060-8543, Japan.
Toshiyoshi FujiwaraDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current status and adoption of cancer-related clinical practice guidelines in Japan has not been elucidated yet. The purpose of this study was to propose roles and suggestions to develop future cancer-related clinical guidelines.

methodsA questionnaire consisting of four domains with a total of 17 questions was developed. We distributed the questionnaire to 28 specific academic organizations in Japan which have developed any cancer-related clinical practice guidelines and which were funded by the Ministry of Health, Labor, and Welfare.

resultsMost organizations have investigated nationwide dissemination and adoption of clinical practice guidelines. The rate of adoption in clinical practice was estimated at approximately ≥ 70%. However, organizations with smaller budgets reported surveying approximately 60% of the time, whereas the ones with larger budgets reported approximately 100% success in surveying about their guidelines. The presidents of the organizations agreed that a new organization operated directly by the national government was necessary.

conclusionIn Japan, to develop cancer-related clinical practice guidelines, a study of clinical validation is necessary. Sufficient funds must be available to support the project to maintain and revise the guidelines. Furthermore, legal and ethical issues should be solved before establishing any registry system.

Indexed as

Evidence-Based MedicineHumansJapanNeoplasmsPractice Guidelines as TopicSurveys and QuestionnairesCancersClinical practice guidelinesJapan Society of Clinical OncologyPlan-do-check-act cycle

Identifiers

PMID30143906
PMCPMC6373226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.